Daniel Aletaha
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 253
- Rheumatoid Arthritis Research and Therapies 223
- Systemic Lupus Erythematosus Research 55
- Spondyloarthritis Studies and Treatments 49
- Hematology 46
- Autoimmune and Inflammatory Disorders Research 43
- Co-authors
- Josef S Smolen (98 shared papers)Josef S Smolen (10 shared papers)Iain B. McInnes (13 shared papers)Josef S Smolen (64 shared papers)Paul Emery (16 shared papers)Tanja Stamm (40 shared papers)Klaus Peter Machold (21 shared papers)Helga Radner (35 shared papers)
- Journals
- Annals of the Rheumatic Diseases (106 papers)Lara D. Veeken (23 papers)RMD Open (20 papers)Arthritis Research & Therapy (18 papers)Arthritis & Rheumatology (9 papers)
- Partner nations
- AustriaUnited StatesUnited Kingdom
In The Last Decade
Daniel Aletaha
318 papers receiving 22.6k citations
Daniel Aletaha's Hit Papers
Peers
Comparison fields: 5 of 160
- Rheumatology 14.3k
- Hematology 2.8k
- Immunology 3.2k
- Genetics 1.2k
- Pathology and Forensic Medicine 976
Countries citing papers authored by Daniel Aletaha
This map shows the geographic impact of Daniel Aletaha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Aletaha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Aletaha more than expected).
Fields of papers citing papers by Daniel Aletaha
This network shows the impact of papers produced by Daniel Aletaha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Aletaha. The network helps show where Daniel Aletaha may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Aletaha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 331 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rheumatoid arthritis Hit paper breakdown → | 2016 | 3681 |
| 2 | Rheumatoid arthritis Hit paper breakdown → | 2018 | 1815 |
| 3 | Diagnosis and Management of Rheumatoid Arthritis Hit paper breakdown → | 2018 | 1671 |
| 4 | Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score Hit paper breakdown → | 2005 | 849 |
| 5 | New therapies for treatment of rheumatoid arthritis Hit paper breakdown → | 2007 | 800 |
| 6 | The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Hit paper breakdown → | 2006 | 694 |
| 7 | Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate Hit paper breakdown → | 2008 | 651 |
| 8 | 2005 | 414 | |
| 9 | Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges Hit paper breakdown → | 2015 | 371 |
| 10 | Distinctions Between Diagnostic and Classification Criteria? Hit paper breakdown → | 2015 | 369 |
| 11 | Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score Hit paper breakdown → | 2015 | 353 |
| 12 | Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update Hit paper breakdown → | 2015 | 261 |
| 13 | 2006 | 246 | |
| 14 | 2005 | 233 | |
| 15 | 2011 | 224 | |
| 16 | 2006 | 217 | |
| 17 | 2012 | 212 | |
| 18 | 2010 | 201 | |
| 19 | 2007 | 197 | |
| 20 | 2008 | 195 |
About Daniel Aletaha
Daniel Aletaha is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 331 papers that have together received 23.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (223 papers), Systemic Lupus Erythematosus Research (55 papers), Spondyloarthritis Studies and Treatments (49 papers), Autoimmune and Inflammatory Disorders Research (43 papers), Chronic Lymphocytic Leukemia Research (18 papers), Biosimilars and Bioanalytical Methods (13 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Rheumatology (14.3k citations), Hematology (2.8k citations), Immunology (3.2k citations), Genetics (1.2k citations) and Pathology and Forensic Medicine (976 citations). Daniel Aletaha has collaborated with scholars based in Austria, United States and United Kingdom. Frequent co-authors include Josef S Smolen, Josef S Smolen, Iain B. McInnes, Josef S Smolen, Paul Emery, Tanja Stamm, Klaus Peter Machold, Helga Radner, Farideh Mohammadi Alasti and Valerie P. K. Nell. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, RMD Open, Arthritis Research & Therapy and Arthritis & Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.